Get 20% lifetime commission for referring investors to digrin.com
here.
X4 Pharmaceuticals, Inc. ( XFOR) - Key Metrics
XFOR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.07 | -$0.13 | -$0.16 | -$0.32 |
| 2026Q1 | $0.02 | -$0.16 | -$0.16 | $0 |
| 2025Q4 | $0.02 | -$0.22 | -$0.14 | -$0.14 |
| 2025Q3 | $0.04 | -$0.69 | -$0.64 | -$0.64 |
| 2025Q2 | $0.27 | -$3.47 | -$4.03 | -$4.03 |
XFOR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -8.98 |
| 2026Q1 | 0% | -6.45 |
| 2025Q4 | 0% | -4.55 |
| 2025Q3 | 0% | -1.24 |
| 2025Q2 | 0% | -0.14 |
XFOR
Price: $4.30
52 week price:
Earnings Per Share: 1.43 USD
P/E Ratio: 3
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 471700
Market Capitalization: 425.3 million